Jenna Cohen | Senior Director and Head, Investor Relations |
Kate Haviland | Chief Executive Officer |
Philina Lee | Chief Commercial Officer |
Becker Hewes | Chief Medical Officer |
Mike Landsittel | Chief Financial Officer |
Fouad Namouni | President, Research & Development |
Christina Rossi | Chief Operating Officer |
Reni Benjamin | JMP Securities |
Brad Canino | Stifel |
Ernie Rodriguez | Cowen and Company |
Dane Leone | Raymond James |
Eun Yang | Jefferies |
Matthew Biegler | Oppenheimer |
Ami Fadia | Needham & Company |
Andrew Berens | SVB Securities |
David Lebowitz | Citi |
Zhiqiang Shu | Berenberg Capital |
Good morning. My name is Kelly. And I'll be your conference operator today. At this time I would like to welcome everyone to the Blueprint Medicines First Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise.